CD274 and central nervous system neoplasm: Particularly CNS tumors impair CAR T-cell efficacy by an adaptive immune suppressive response including upregulation of immune inhibitory molecules, such as programmed cell death ligand-1 (PD-L1) resulting in immune cell exhaustion [18].